TY  - BOOK
AU  - Fuchs,Flávio Danni
TI  - Essentials of Hypertension: The 120/80 Paradigm
SN  - 9783319632728
AV  - RC666-701.2 
U1  - 616.132 
PY  - 2017///
CY  - Cham
PB  - Springer International Publishing AG
KW  - Hypertension
KW  - Electronic books
N1  - Intro -- Preface -- Acknowledgments -- Contents -- 1: Risks of High Blood Pressure and Goals for Treatment -- 1.1  Risks for Coronary Heart Disease, Stroke, and Cardiovascular Mortality -- 1.2  Other Risks of High Blood Pressure -- 1.2.1  Heart Failure -- 1.2.2  Aortic Valve Stenosis and other heart valve diseases -- 1.2.3  Atrial Fibrillation -- 1.2.4  Aortic Stiffness and Aortic Syndromes -- 1.2.5  Peripheral Arterial Disease -- 1.2.6  Chronic Kidney Disease -- 1.2.7  Dementias -- 1.2.8  Diabetes Mellitus -- 1.2.9  Age-Related Macular Degeneration -- 1.2.10  Erectile Dysfunction -- 1.3  Populations at Risk and Trends in High Blood Pressure -- 1.4  Diagnostic Thresholds: Recommendations from Hypertension Guidelines -- 1.5  Proof of Concept: Experimental Evidence -- 1.6  Goals for Treatment and the J-Shaped Phenomenon -- 1.7  SPRINT -- 1.8  Benefits of Treating Prehypertension -- 1.9  Low Blood Pressure: The Key to a Long and Healthier Life -- 1.10  Misconceptions and Lack of Action -- 1.11  Blood Pressure Classification -- References -- 2: Pathogenesis -- 2.1  Maladaptation to Sodium Overload -- 2.1.1  Epidemiological Evidence -- 2.1.2  Salt Sensitivity -- 2.1.3  The Central Role of the Kidneys in the Pathogenesis of Hypertension -- 2.1.4  Proof of Concept: The Role of Intrinsic Renal Capacity to Handle Salt Overload in the Pathogenesis of Hypertension -- 2.2  Excessive Adiposity -- 2.3  Diabetes and Metabolic Syndrome -- 2.4  Potassium and Other Dietary Factors -- 2.5  Alcohol, Hypertension, and Cardiovascular Disease -- 2.6  Sleep Disorders -- 2.7  Stress -- 2.8  Other Risks for Hypertension -- 2.8.1  Socioeconomic and Educational Risks -- 2.8.2  Depression -- 2.8.3  Oral Contraceptives -- 2.8.4  Shift Work -- 2.8.5  Endothelial Dysfunction -- 2.8.6  Oxidative Stress and Inflammation -- 2.8.7  Other Risks -- References; 3: Diagnosis and Evaluation -- 3.1  Blood Pressure Measurement -- 3.2  Daily Blood Pressure Load and the Concept of Casual and Usual Blood Pressure -- 3.3  Precision of Methods Used to Estimate Risks of High Blood Pressure -- 3.4  White-Coat and Masked Hypertension -- 3.4.1  Diagnostic Thresholds for Out-of-Office Blood Pressure Measurement -- 3.5  Clinical Evaluation -- 3.5.1  Headache -- 3.5.2  Epistaxis -- 3.5.3  Quality of Life -- 3.5.4  Musculoskeletal Complaints -- 3.5.5  Other Findings in the Medical History -- 3.5.6  Physical Examination -- 3.5.7  Laboratory Data -- 3.6  Risk Stratification -- 3.6.1  Electrocardiography -- 3.6.2  Echocardiography -- 3.6.3  Development of Clinical Disease -- 3.6.4  Optic Fundus Abnormalities -- 3.6.5  Aortic Stiffness and Peripheral Arterial Disease -- 3.7  Blood Pressure Variability -- 3.8  Resistant Hypertension -- 3.9  Secondary Hypertension -- References -- 4: Prevention and Treatment -- 4.1  Nonpharmacological Therapies -- 4.1.1  Reduction of Salt Intake -- 4.1.1.1  In Populations -- 4.1.1.2  In Individuals with Normal and High Blood Pressure -- 4.1.2  Hypocaloric Diet -- 4.1.3  DASH Diet -- 4.1.4  PREDIMED Diet -- 4.1.5  Supplementation of Potassium, Calcium, and Magnesium -- 4.1.6  Comparative Effectiveness of Dietary Interventions -- 4.1.7  Other Nutritional Interventions -- 4.1.7.1  Alcoholic Beverage Consumption -- 4.1.7.2  Chocolate and Other Cocoa Products -- 4.1.7.3  Other Nutraceuticals -- 4.1.7.4  Probiotics -- 4.1.8  Physical Activity -- 4.1.9  Treatment of Obstructive Sleep Apnea as a Means to Treat Hypertension -- 4.1.10  Oral Contraceptives and Hormone Replacement Therapy -- 4.1.11  Surgical Treatment of Hypertension -- 4.1.11.1  Renovascular Hypertension -- 4.1.11.2  Renal Sympathetic Denervation -- 4.1.11.3  Bariatric Surgery -- 4.1.12  Other Nonpharmacological Treatments; 4.1.12.1  Behavioral Therapies -- 4.1.12.2  Acupuncture -- 4.1.12.3  Device-Guided Breathing Modulation -- 4.2  Drug Treatment -- 4.2.1  Pioneering Studies -- 4.2.2  The First Choice -- 4.2.3  Diuretic Preference and Association with Potassium-­Sparing Agents -- 4.2.4  Other Options for the First Choice -- 4.2.5  Second-Line and Third-Line Drugs for Management of Hypertension -- 4.2.6  Management of Resistant Hypertension -- 4.2.7  Adverse Events, Adverse Effects, and the Nocebo Effect -- 4.2.8  Hypertensive Crises, Urgencies, and Emergencies -- 4.2.9  Strategies to Improve Adherence to Treatment -- 4.2.9.1  Self-Monitoring of Blood Pressure -- 4.2.9.2  Telemonitoring -- 4.2.9.3  Pharmacist Care -- 4.2.9.4  Text Messages -- References -- Erratum to: Diagnosis and Evaluation -- Index
UR  - https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5152964
ER  -